Elias et al identified prognostic factors for patients with peritoneal carcinomatosis associated with colorectal carcinoma. These factors can identify a patient who may benefit from more aggressive therapy or be a candidate for a novel therapy. The authors are from multiple hospitals in France, Belgium and Canada.
Parameters:
(1) cytoreductive surgery
(2) extent of peritoneal carcinomatosis (using the Peritoneal Cancer Indiex, PCI)
(3) lymph node metastases
(4) adjuvant chemotherapy
Parameter |
Findings |
Points |
cytoreductive surgery |
none or partial |
0 |
|
complete |
1 |
extent of peritoneal carcinomatosis |
not limited |
0 |
|
limited (PCI <= 6) |
1 |
lymph node metastases |
present |
0 |
|
absent |
1 |
adjuvant chemotherapy |
not given |
0 |
|
given |
1 |
where:
• Extent of peritoneal carcinomatosis showed 3 survival curves: best if PCI <= 6, intermediate if PCI 7 to 19 and worst for PCI > 19.
• Cytoreductive surgery showed 3 survival curves: best if complete (no residual tumor), intermediate for a little and worst for a lot.
number of factors associated with a better prognosis =
= SUM(points for all 4 parameters)
Interpretation:
• minimum number of factors: 0
• maximum number of factors: 4
• The prognosis improved as the number of favorable factors increased.
• Tumor grade and liver metastases did not impact prognosis (but would impact lymph node metastases and extent of peritoneal carcinomatosis).
Specialty: Hematology Oncology, Surgery, general
ICD-10: ,